Functional Relevance of the Switch of VEGF Receptors/Co-Receptors during Peritoneal Dialysis-Induced Mesothelial to Mesenchymal Transition

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Pérez Lozano, María Luisa ^a   Sandoval, Pilar ^a   Rynne Vidal, Ángela ^a   Aguilera, Abelardo ^b   Jiménez Heffernan, José Antonio ^c   Albar Vizcaíno, Patricia ^b   Majano, Pedro L ^b   Sánchez Tomero, José Antonio ^b   Selgas, Rafael ^d   López Cabrera, Manuel ^a  

^a CSIC   (Spain)

^b Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; NEUROPILIN 1; SEMAPHORIN 3A; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN ANTIBODY; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ARTICLE; CELL INVASION; CELL PROLIFERATION; CELLULAR PARAMETERS; CONTROLLED STUDY; DOWN REGULATION; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MESOTHELIAL MESENCHYMAL TRANSITION; MESOTHELIUM CELL; MOLECULAR MODEL; OMENTUM; PERITONEAL DIALYSIS; PHARMACOLOGICAL BLOCKING; PHENOTYPIC VARIATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; UPREGULATION;

ADULT; AGED; ANTIBODIES, NEUTRALIZING; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; NEUROPILIN-1; OMENTUM; PERITONEAL DIALYSIS; PRIMARY CELL CULTURE; SEMAPHORIN-3A; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84876054807     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060776     Document Type: Article

References (75)

1. Krediet RT, Zweers MM, van der Wal AC, Struijk DG, (2000) Neoangiogenesis in the peritoneal membrane. Perit Dial Int 20Suppl 2: S19-25.
2. Aroeira LS, Aguilera A, Sanchez-Tomero JA, Bajo MA, del Peso G, et al. (2007) Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol 18: 2004-2013.
3. Margetts PJ, Bonniaud P, (2003) Basic mechanisms and clinical implications of peritoneal fibrosis. Perit Dial Int 23: 530-541.
4. Yanez-Mo M, Lara-Pezzi E, Selgas R, Ramírez-Huesca M, Dominguez-Jimenez C, et al. (2003) Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 348: 403-413.
5. Loureiro J, Aguilera A, Selgas R, Sandoval P, Albar-Vizcaíno P, et al. (2011) Blocking TGF-beta1 protects the peritoneal membrane from dialysate-induced damage. J Am Soc Nephrol 22: 1682-1695.
6. Thiery JP, Sleeman JP, (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142.
7. Thiery JP, Acloque H, Huang RY, Nieto MA, (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890.
8. Aroeira LS, Lara-Pezzi E, Loureiro J, Aguilera A, Ramírez-Huesca M, et al. (2009) Cyclooxygenase-2 mediates dialysate-induced alterations of the peritoneal membrane. J Am Soc Nephrol 20: 582-592.
9. Ha H, Cha MK, Choi HN, Lee HB, (2002) Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells. Perit Dial Int 22: 171-177.
10. Selgas R, del Peso G, Bajo MA, Castro MA, Molina S, et al. (2000) Spontaneous VEGF production by cultured peritoneal mesothelial cells from patients on peritoneal dialysis. Perit Dial Int 20: 798-801.
11. Aroeira LS, Aguilera A, Selgas R, Ramírez-Huesca M, Pérez-Lozano ML, et al. (2005) Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor. Am J Kidney Dis 46: 938-948.
12. Sandoval P, Loureiro J, González-Mateo G, Pérez-Lozano ML, Maldonado-Rodríguez A, et al. (2010) PPAR-gamma agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage. Lab Invest 90: 1517-1532.
13. Ferrara N, (1999) Vascular endothelial growth factor: molecular and biological aspects. Curr Top Microbiol Immunol 237: 1-30.
14. Carmeliet P, Tessier-Lavigne M, (2005) Common mechanisms of nerve and blood vessel wiring. Nature 436: 193-200.
15. Cross MJ, Dixelius J, Matsumoto T, Claesson-Welsh L, (2003) VEGF-receptor signal transduction. Trends Biochem Sci 28: 488-494.
16. Ferrara N, Gerber HP, LeCouter J, (2003) The biology of VEGF and its receptors. Nat Med 9: 669-676.
17. Gu C, Limberg BJ, Whitaker GB, Perman B, Leahy DJ, et al. (2002) Characterization of neuropilin-1 structural features that confer binding to semaphorin 3A and vascular endothelial growth factor 165. J Biol Chem 277: 18069-18076.
18. Cai H, Reed, R R, (1999) Cloning and characterization of neuropilin-1-interacting protein: a PSD-95/Dlg/ZO-1 domain-containing protein that interacts with the cytoplasmic domain of neuropilin-1. J Neurosci 19: 6519-6527.
19. He Z, Tessier-Lavigne M, (1997) Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell 90: 739-751.
20. Kolodkin AL, Levengood DV, Rowe EG, Tai YT, Giger RJ, et al. (1997) Neuropilin is a semaphorin III receptor. Cell 90: 753-762.
21. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M, (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92: 735-745.
22. Bachelder RE, Wendt MA, Mercurio AM, (2002) Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res 62: 7203-7206.
23. Wang L, Zeng H, Wang P, Soker S, Mukhopadhyay D, (2003) Neuropilin-1-mediated vascular permeability factor/vascular endothelial growth factor-dependent endothelial cell migration. J Biol Chem 278: 48848-48860.
24. Li M, Yang H, Chai H, Fisher WE, Wang X, et al. (2004) Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors. Cancer 101: 2341-2350.
25. Murga M, Fernandez-Capetillo O, Tosato G, (2005) Neuropilin-1 regulates attachment in human endothelial cells independently of vascular endothelial growth factor receptor-2. Blood 105: 1992-1999.
26. Cariboni A, Davidson K, Dozio E, Memi F, Schwarz Q, et al. (2011) VEGF signalling controls GnRH neuron survival via NRP1 independently of KDR and blood vessels. Development 138: 3723-3733.
27. Pan Q, Chanthery Y, Liang WC, Stawicki S, Mak J, et al. (2007) Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth. Cancer Cell 11: 53-67.
28. Appleton BA, Wu P, Maloney J, Yin J, Liang WC, et al. (2007) Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding. EMBO J 26: 4902-4912.
29. Rossignol M, Gagnon ML, Klagsbrun M, (2000) Genomic organization of human neuropilin-1 and neuropilin-2 genes: identification and distribution of splice variants and soluble isoforms. Genomics 70: 211-222.
30. Narazaki M, Tosato G, (2006) Ligand-induced internalization selects use of common receptor neuropilin-1 by VEGF165 and semaphorin3A. Blood 107: 3892-3901.
31. Matsushita A, Gotze T, Korc M, (2007) Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1. Cancer Res 67: 10309-10316.
32. West DC, Rees CG, Duchesne L, Patey SJ, Terry CJ, et al. (2005) Interactions of multiple heparin binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor-2. J Biol Chem 280: 13457-13464.
33. Glinka Y, Prud'homme GJ, (2008) Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity. J Leukoc Biol 84: 302-310.
34. Glinka Y, Stoilova S, Mohammed N, Prud'homme GJ, (2011) Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta. Carcinogenesis 32: 613-621.
35. Tordjman R, Lepelletier Y, Lemarchandel V, Cambot M, Gaulard P, et al. (2002) A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response. Nat Immunol 3: 477-482.
36. Yamada Y, Oike Y, Ogawa H, Ito Y, Fujisawa H, et al. (2003) Neuropilin-1 on hematopoietic cells as a source of vascular development. Blood 101: 1801-1809.
37. Catalano A, Caprari P, Rodilossi S, Betta P, Castellucci M, et al. (2004) Cross-talk between vascular endothelial growth factor and semaphorin-3A pathway in the regulation of normal and malignant mesothelial cell proliferation. Faseb J 18: 358-360.
38. Liu W, Parikh AA, Stoeltzing O, Fan F, McCarty MF, et al. (2005) Upregulation of neuropilin-1 by basic fibroblast growth factor enhances vascular smooth muscle cell migration in response to VEGF. Cytokine 32: 206-212.
39. Kurschat P, Bielenberg D, Rossignol-Tallandier M, Stahl A, Klagsbrun M, (2006) Neuron restrictive silencer factor NRSF/REST is a transcriptional repressor of neuropilin-1 and diminishes the ability of semaphorin 3A to inhibit keratinocyte migration. J Biol Chem 281: 2721-2729.
40. Latil A, Bieche I, Pesche S, Valeri A, Fournier G, et al. (2000) VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms. Int J Cancer 89: 167-171.
41. Parikh AA, Fan F, Liu WB, Ahmad SA, Stoeltzing O, et al. (2004) Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis. Am J Pathol 164: 2139-2151.
42. Hansel DE, Wilentz RE, Yeo CJ, Schulick RD, Montgomery E, et al. (2004) Expression of neuropilin-1 in high-grade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract. Am J Surg Pathol 28: 347-356.
43. Barr MP, Byrne AM, Duffy AM, Condron CM, Devocelle M, et al. (2005) A peptide corresponding to the neuropilin-1-binding site on VEGF(165) induces apoptosis of neuropilin-1-expressing breast tumour cells. Br J Cancer 92: 328-333.
44. Baba T, Kariya M, Higuchi T, Mandai M, Matsumura N, et al. (2007) Neuropilin-1 promotes unlimited growth of ovarian cancer by evading contact inhibition. Gynecol Oncol 105: 703-711.
45. Fukasawa M, Matsushita A, Korc M, (2007) Neuropilin-1 interacts with integrin beta1 and modulates pancreatic cancer cell growth, survival and invasion. Cancer Biol Ther 6: 1173-1180.
46. Pallaoro A, Braun GB, Moskovits M, (2011) Quantitative ratiometric discrimination between noncancerous and cancerous prostate cells based on neuropilin-1 overexpression. Proc Natl Acad Sci U S A 108: 16559-16564.
47. Berge M, Allanic D, Bonnin P, de Montrion C, Richard J, et al. (2011) Neuropilin-1 is upregulated in hepatocellular carcinoma and contributes to tumour growth and vascular remodelling. J Hepatol 55: 866-875.
48. Jubb AM, Strickland LA, Liu SD, Mak J, Schmidt M, et al. (2012) Neuropilin-1 expression in cancer and development. J Pathol 226: 50-60.
49. Liang WC, Dennis MS, Stawicki S, Chanthery Y, Pan Q, et al. (2007) Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library. J Mol Biol 366: 815-829.
50. Bagri A, Tessier-Lavigne M, Watts RJ, (2009) Neuropilins in tumor biology. Clin Cancer Res 15: 1860-1864.
51. Haixia D, Jingsong Z, Lei J, Hairong D, Jun W, et al. (2011) Gene expression of neuropilin-1 and its receptors, VEGF/Semaphorin 3a, in normal and cancer cells. Cell Biochem Biophys 59: 39-47.
52. Bajo MA, Pérez-Lozano ML, Albar-Vizcaíno P, del Peso G, Castro MJ, et al. (2011) Low-GDP peritoneal dialysis fluid ('balance') has less impact in vitro and ex vivo on epithelial-to-mesenchymal transition (EMT) of mesothelial cells than a standard fluid. Nephrol Dial Transplant 26: 282-291.
53. Fernandez-Perpen A, Pérez-Lozano ML, Bajo MA, Albar-Vizcaíno P, Correa PS, et al. (2012) Influence of Bicarbonate/Low-GDP Peritoneal Dialysis Fluid (Bicavera) on In Vitro and Ex Vivo Epithelial-to-Mesenchymal Transition of Mesothelial Cells. Perit Dial Int 32: 292-304.
54. Selgas R, Fernández-Reyes MJ, Bosque E, Bajo MA, Borrego F, et al. (1994) Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study. Am J Kidney Dis 23: 64-73.
55. Ho-dac-Pannekeet MM, Atasever B, Struijk DG, Krediet RT, (1997) Analysis of ultrafiltration failure in peritoneal dialysis patients by means of standard peritoneal permeability analysis. Perit Dial Int 17: 144-150.
56. López-Cabrera M, Aguilera A, Aroeira LS, Ramírez-Huesca M, Pérez-Lozano ML, et al. (2006) Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure. Perit Dial Int 26: 26-34.
57. Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD, (1990) Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 37: 1563-1570.
58. Strippoli R, Benedicto I, Pérez Lozano ML, Cerezo A, López-Cabrera M, et al. (2008) Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK/NF-kappaB/Snail1 pathway. Dis Model Mech 1: 264-274.
59. Strippoli R, Benedicto I, Foronda M, Perez-Lozano ML, Sanchez-Perales S, et al. (2010) p38 maintains E-cadherin expression by modulating TAK1-NF-kappa B during epithelial-to-mesenchymal transition. J Cell Sci 123: 4321-4331.
60. Lai KN, Lai KB, Lam CW, Chan TM, Li FK, et al. (2000) Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 35: 644-652.
61. Yang WS, Kim BS, Lee SK, Park JS, Kim SB, (1999) Interleukin-1beta stimulates the production of extracellular matrix in cultured human peritoneal mesothelial cells. Perit Dial Int 19: 211-220.
62. Zweers MM, de Waart DR, Smit W, Struijk DG, Krediet RT, (1999) Growth factors VEGF and TGF-beta1 in peritoneal dialysis. J Lab Clin Med 134: 124-132.
63. Bagnard D, Vaillant C, Khuth ST, Dufay N, Lohrum M, et al. (2001) Semaphorin 3A-vascular endothelial growth factor-165 balance mediates migration and apoptosis of neural progenitor cells by the recruitment of shared receptor. J Neurosci 21: 3332-3341.
64. Del Peso G, Jimenez-Heffernan JA, Bajo MA, Aroeira LS, Aguilera A, et al. (2008) Epithelial-to-mesenchymal transition of mesothelial cells is an early event during peritoneal dialysis and is associated with high peritoneal transport. Kidney Int Suppl: S26-33.
65. Mizutani M, Ito Y, Mizuno M, Nishimura H, Suzuki Y, et al. (2010) Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate. Am J Physiol Renal Physiol 298: F721-733.
66. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, et al. (2002) Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13: 470-479.
67. Numata M, Nakayama M, Nimura S, Kawakami M, Lindholm B, et al. (2003) Association between an increased surface area of peritoneal microvessels and a high peritoneal solute transport rate. Perit Dial Int 23: 116-122.
68. Pecoits-Filho R, Araujo MR, Lindholm B, Stenvinkel P, Abensur H, et al. (2002) Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 17: 1480-1486.
69. Boulanger E, Grossin N, Wautier MP, Taamma R, Wautier JL, (2007) Mesothelial RAGE activation by AGEs enhances VEGF release and potentiates capillary tube formation. Kidney Int 71(2): 126-133.
70. Paruchuri S, Yang JH, Aikawa E, Melero-Martin JM, Khan ZA, et al. (2006) Human pulmonary valve progenitor cells exhibit endothelial/mesenchymal plasticity in response to vascular endothelial growth factor-A and transforming growth factor-beta2. Circulation research 99(8): 861-869.
71. Medici D, Shore EM, Lounev VY, Kaplan FS, Kalluri R,et al. Conversion of vascular endothelial cells into multipotent stem-like cells. Nature medicine 16(12): 1400-1406.
72. Vega S, Morales AV, Ocana OH, Valdes F, Fabregat I, et al. (2004) Snail blocks the cell cycle and confers resistance to cell death. Genes Dev 18: 1131-1143.
73. Yu MA, Shin KS, Kim JH, Kim YI, Chung SS, et al. (2009) HGF and BMP-7 ameliorate high glucose-induced epithelial-to-mesenchymal transition of peritoneal mesothelium. J Am Soc Nephrol 20: 567-581.
74. Loureiro J, Schilte M, Aguilera A, Albar-Vizcaíno P, Ramírez-Huesca M, et al. (2010) BMP-7 blocks mesenchymal conversion of mesothelial cells and prevents peritoneal damage induced by dialysis fluid exposure. Nephrol Dial Transplant 25: 1098-1108.
75. Kihm LP, Muller-Krebs S, Klein J, Ehrlich G, Mertes L,et al. Benfotiamine protects against peritoneal and kidney damage in peritoneal dialysis. J Am Soc Nephrol 22: 914-926.